| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/06/2006 | WO2006011859A3 Preparation of hydrochloride salts of tetrazole derivative |
| 07/06/2006 | WO2006011159A3 Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability |
| 07/06/2006 | WO2006010147A3 Control of biofilm formation |
| 07/06/2006 | WO2006005741A3 Piperdine derivatives as renin inhibitors |
| 07/06/2006 | WO2006002233A3 Alvaradoins e-n, new antitumor and cytotoxic anthracenone g-glycosides |
| 07/06/2006 | WO2005117829A8 Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance |
| 07/06/2006 | WO2005116002A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/06/2006 | WO2005115346A3 Pharmaceutical composition containing risperidone |
| 07/06/2006 | WO2005110505A3 Hyaluronic acid based copolymers |
| 07/06/2006 | WO2005110462A3 Methods and compositions for treatment of preeclampsia |
| 07/06/2006 | WO2005105096A3 Fused heterocyclic compounds |
| 07/06/2006 | WO2005097993A3 Immunostimulatory viral rna oligonucleotides |
| 07/06/2006 | WO2005086902A3 Ion channel modulators |
| 07/06/2006 | WO2005079464A3 Vitamin d receptor antagonists and their use in treating asthma |
| 07/06/2006 | WO2005041867A8 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3’(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline |
| 07/06/2006 | WO2005034868A8 Methods for treating igf1r-inhibitor induced hyperglycemia |
| 07/06/2006 | WO2004062603A3 Methods of treating lung diseases |
| 07/06/2006 | WO2004043232A3 Methods for identifying risk of melanoma and treatments thereof |
| 07/06/2006 | US20060149318 Ergonomic ped-hydro cavity agitation for therapeutic assistance and relaxation use |
| 07/06/2006 | US20060149182 Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 07/06/2006 | US20060149092 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/06/2006 | US20060149080 Process for preparing optically active cyclic amines |
| 07/06/2006 | US20060149078 Olmesartan medoxomil with reduced levels of impurities |
| 07/06/2006 | US20060149075 Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione |
| 07/06/2006 | US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 07/06/2006 | US20060149059 Phthalazinone derivatives |
| 07/06/2006 | US20060149056 Stable bioavailable crystalline form of cefdinir and a process for the preparation thereof |
| 07/06/2006 | US20060149045 Steroid compounds with anti-tumor activity |
| 07/06/2006 | US20060148908 Supressant of toxicity induced by cancer chemotherapeutic agent and composition of cancer chemotherapeutic agent containing the same |
| 07/06/2006 | US20060148907 Topical antinflammatory preparations of y-terpinene |
| 07/06/2006 | US20060148906 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 07/06/2006 | US20060148905 Administering to a subject suffering from the beta-Amyloid protein-induced cytotoxicity, ketone compounds isolated from turmeric, gingko biloba, and ginger, and synthetic chemical analogues |
| 07/06/2006 | US20060148904 Substituted ethylene diamines for the treatment of infectious diseases; used for mycobacterial infections, including tuberculosis |
| 07/06/2006 | US20060148903 Capsaicinoid gel formulation and uses thereof |
| 07/06/2006 | US20060148902 Process for the preparation of nateglinide, preferably in B-form |
| 07/06/2006 | US20060148901 Acylated 4-amidino-and-4-guanidinobenzylamines for inhibition of plasma kallikrein |
| 07/06/2006 | US20060148900 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 07/06/2006 | US20060148899 Ophthalmic compositions and methods of using the same |
| 07/06/2006 | US20060148898 Curing and prophylactic agent applied during the use of alcohol and psychoactive substances |
| 07/06/2006 | US20060148897 Method for sterilization using in situ gelling materials |
| 07/06/2006 | US20060148896 Use of an alkanoyl L-carnitine for the preparation of a medication to treat anhedonia |
| 07/06/2006 | US20060148895 New composition use and method |
| 07/06/2006 | US20060148894 12-Aryl prostaglandin analogs |
| 07/06/2006 | US20060148893 Chemical compounds |
| 07/06/2006 | US20060148891 Formulations of thiomolybdate or thiotungstate compounds and uses thereof |
| 07/06/2006 | US20060148890 Substituted furochromene compounds of antiinflammatory action |
| 07/06/2006 | US20060148889 2-(4-Hydroxy-2-oxo-2H-chromene-3-yl)-4H-furo[3,2-c]chromene-4-one; prophylaxis and treatment of allergies, asthma and other inflammatory diesases |
| 07/06/2006 | US20060148888 Chroman derivatives and uses thereof |
| 07/06/2006 | US20060148887 Chemical compounds |
| 07/06/2006 | US20060148885 Medicinal composition |
| 07/06/2006 | US20060148884 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 07/06/2006 | US20060148883 Medicaments for the Treatment or Prevention of Fibrotic Diseases |
| 07/06/2006 | US20060148882 Methods of using and compositions comprising PDE4 modulators for treatment, prevention and management airway inflammation |
| 07/06/2006 | US20060148881 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-Benzodioxan |
| 07/06/2006 | US20060148880 3-(Guanidinylcarbonylmethyl)-substituted; inhibit the cellular sodium-proton antiporter, in particular NHE1; antiarrhythmic agents;cardioprotective for infarction prophylaxis and treatment; preventing ischemia-induced damage |
| 07/06/2006 | US20060148879 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases |
| 07/06/2006 | US20060148878 Pseudopolymorphic forms of carvedilol |
| 07/06/2006 | US20060148877 Pharmaceutical formulations of celcoxib |
| 07/06/2006 | US20060148876 Nr3b1 nuclear receptor binding 3-substituted pyrazoles |
| 07/06/2006 | US20060148875 Agent for prophylaxis and treatment of diabetic complications |
| 07/06/2006 | US20060148874 Compounds for use in the treatment of aids and other viral diseases and HIV-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions |
| 07/06/2006 | US20060148872 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one |
| 07/06/2006 | US20060148871 Metabolic stabilization of substituted adamantane |
| 07/06/2006 | US20060148870 Process for preparing olmesartan medoxomil AT pH higher than 2.5 |
| 07/06/2006 | US20060148869 Halogenated biaryl heterocyclic compounds and methods of making and using the same |
| 07/06/2006 | US20060148868 Zolmitriptan polymorphs |
| 07/06/2006 | US20060148867 Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof |
| 07/06/2006 | US20060148866 Novel process for preparing pramipexole and its optical isomeric mixture by reduction with sodium triacetoxyborohydride |
| 07/06/2006 | US20060148865 Preparation of chemical compounds |
| 07/06/2006 | US20060148864 Treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay such as genetic disorders |
| 07/06/2006 | US20060148863 E.g., 3-[5-(2-Chloro-pyridin-3-yl)-[1,2,4]oxadiazol-3-yl]-benzoic acid; treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay such as genetic disorders |
| 07/06/2006 | US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 07/06/2006 | US20060148861 For treatment of psychotic disorders including schizophrenia, anxiety, depression and bipolar disorders; neurodegenerative diseases, epilepsy and pain including headaches and migraines |
| 07/06/2006 | US20060148860 Substituted p-phenyl carbamates |
| 07/06/2006 | US20060148858 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity |
| 07/06/2006 | US20060148857 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 07/06/2006 | US20060148856 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 07/06/2006 | US20060148855 Carboxamide derivatives |
| 07/06/2006 | US20060148854 Chemical compounds |
| 07/06/2006 | US20060148852 Visual function disorder improving agents |
| 07/06/2006 | US20060148851 Fexofenadine crystal form and processes for its preparation thereof |
| 07/06/2006 | US20060148850 4-{'3-(Sulfonylamino) phenyl!'1-(cyclymethyl) piperidin-4-ylidene! methyl}benazmide derivativess as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder |
| 07/06/2006 | US20060148849 Quinoline derivatives, process of synthesis and medicaments containing these derivatives |
| 07/06/2006 | US20060148848 Compounds and methods for treating cancer and inflammation |
| 07/06/2006 | US20060148847 Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/06/2006 | US20060148846 Crystalline forms of a factor Xa inhibitor |
| 07/06/2006 | US20060148845 In which a pyrrole ring is directly bonded to a 6,5-condensed ring system, such as a benzimidazole, imidazopyridine or imidazopyrimidine system; especially effective against drug resistant bacteria such as MRSA, PRSP, or VRE |
| 07/06/2006 | US20060148844 Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation |
| 07/06/2006 | US20060148843 e.g.1-(4-Chloro-benzyl)-3-(2-methyl-thieno[2,3-c]pyridin-3-yl)-urea; 2-Methyl-thieno[2,3-c]pyridin-3-yl)-carbamic acid 4-trifluoromethylsulfanyl-benzyl ester; controlling pain, urinary incontinence, bladder overactivity, and inflammatory thermal hyperalgesia in mammals |
| 07/06/2006 | US20060148842 Nepetalactams and N-substituted derivatives thereof |
| 07/06/2006 | US20060148841 Pharmaceutical composition comprising combination of non-alkaloid and alkaloid-based component for treating skeletal muscle spasm |
| 07/06/2006 | US20060148840 Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 07/06/2006 | US20060148839 New pharmaceutical compositions based on anticholinergics and tace-inhibitors |
| 07/06/2006 | US20060148838 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 07/06/2006 | US20060148837 Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction |
| 07/06/2006 | US20060148836 drugs such as 6-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl]nicotinic acid used as antiinflammatory agents and/or for treating autoimmune diseases |
| 07/06/2006 | US20060148835 Mglu receptors antagonists for treating disorders associated with mglu receptors including addiction and depression |
| 07/06/2006 | US20060148834 Novel coumarin-amide derivatives and its preparation, said drug composition and its use |
| 07/06/2006 | US20060148833 Use of chymase inhibitors for the prevention and/or treatment of arterio-venous graft failure |
| 07/06/2006 | US20060148832 Use of 2-amino-2h-quinazoline derivatives for producing therapeutic agents |